SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-028769
Filing Date
2023-10-23
Accepted
2023-10-23 16:44:26
Documents
14
Period of Report
2023-10-18
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnpx20231017_8k.htm   iXBRL 8-K 28269
2 EXHIBIT 3.1 ex_582314.htm EX-3.1 4100
  Complete submission text file 0001437749-23-028769.txt   176777

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20231018.xsd EX-101.SCH 3410
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20231018_def.xml EX-101.DEF 12568
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20231018_lab.xml EX-101.LAB 16935
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20231018_pre.xml EX-101.PRE 12893
8 EXTRACTED XBRL INSTANCE DOCUMENT gnpx20231017_8k_htm.xml XML 2818
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

IRS No.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38244 | Film No.: 231340376
SIC: 2834 Pharmaceutical Preparations